Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine for agitation during post-traumatic amnesia after traumatic brain injury
ACTRN12619000284167Phase 2Recruiting
- Sponsor
- Monash University
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of olanzapine in agitation, traumatic brain injury (TBI) and Post-traumatic confusional state (PTCS), sponsored by Monash University. Primary endpoint: Mean level of agitation. Started Aug 2019; status: recruiting.
02
Drugs
olanzapine
03
Conditions
agitationtraumatic brain injury (TBI)Post-traumatic confusional state (PTCS)
Beyond the preview
Go deeper on ACTRN12619000284167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619000284167.